Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Cystic fibrosis (CF) is a chronic disease that significantly affects an individual's lung
function. Antibiotic medications have been proven effective at reducing Pseudomonas
aeruginosa (PA) infection, which is one of the main causes of death in individuals with CF.
The purpose of this study is to compare the effectiveness of treatment based on quarterly
culture results versus consistent quarterly antibiotic treatment at reducing PA infection in
children with CF.
Phase:
Phase 2
Details
Lead Sponsor:
Seattle Children's Hospital
Collaborators:
CF Therapeutics Development Network Coordinating Center Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics National Heart, Lung, and Blood Institute (NHLBI)